Changes in the Use of Montelukast for Asthma After a US Food and Drug Administration Boxed Warning

• by Hariharan Shanmugam, Aaron S. Kesselheim, Ian T. T. Liu, William B. Feldman, Benjamin N. Rome

• May 22, 2026

FDA Clears Breztri for Asthma Use

Single-inhaler triple therapy improved lung function vs dual therapy in phase 3 trials and showed rapid onset without new safety signals.

• by Kathryn Wighton

• April 28, 2026

• 2 min

Low Follow-Up After Behavioral ED Care

Follow-up occurred after fewer than 15% of mental health ED visits and about 11% of substance use–related visits in Washington Medicaid claims.

• by Kathryn Wighton

• May 5, 2026

• 5 min

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

• by Kathryn Wighton

• May 12, 2026

• 2 min